Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bannantine, J. P. Articles by Kapur, V. Search for Related Content PubMed PubMed Citation Articles by Bannantine, J. P. Articles by Kapur, V.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2004, p. 106-114, Vol. 42, No. 1
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.1.106-114.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Expression and Immunogenicity of Proteins Encoded by Sequences Specific to Mycobacterium avium subsp. paratuberculosis

John P. Bannantine,^1* Janis K. Hansen,¹ Michael L. Paustian,¹ Alongkorn Amonsin,² Ling-Ling Li,² Judith R. Stabel,¹ and Vivek Kapur²

National Animal Disease Center, USDA Agricultural Research Service, Ames, Iowa 50010,¹ Biomedical Genomics Center and Departments of Microbiology and Veterinary Pathobiology, University of Minnesota, Minneapolis, Minnesota 55488²

Received 3 June 2003/ Returned for modification 22 July 2003/ Accepted 26 August 2003

Top Abstract Introduction Materials and Methods Results Discussion References

 
The development of immunoassays specific for the diagnosis of Johne's disease in cattle requires antigens specific to Mycobacterium avium subsp. paratuberculosis. However, because of genetic similarity to other mycobacteria comprising the M. avium complex, no such antigens have been found. Through a comparative genomics approach, 21 potential coding sequences of M. avium subsp. paratuberculosis that are not represented in any other mycobacterial species tested (n = 9) were previously identified (J. P. Bannantine, E. Baechler, Q. Zhang, L. Li, and V. Kapur, J. Clin. Microbiol. 40:1303-1310, 2002). Here we describe the cloning, heterologous expression, and antigenic analysis of these M. avium subsp. paratuberculosis-specific sequences in Escherichia coli. Nucleotide sequences representing each unique predicted coding region were amplified and cloned into two different E. coli expression vectors encoding polyhistidine or maltose binding protein (MBP) affinity purification tags. All 21 of the MBP fusion proteins were successfully purified under denaturing conditions and were evaluated in immunoblotting studies with sera from rabbits and mice immunized with M. avium subsp. paratuberculosis. These studies showed that 5 of the 21 gene products are produced by M. avium subsp. paratuberculosis and are antigenic. Immunoblot analysis with a panel of sera from 9 healthy cattle and 10 cattle with clinical disease shows that the same five M. avium subsp. paratuberculosis proteins are also detected within the context of infection. Collectively, these studies have used a genomic approach to identify novel M. avium subsp. paratuberculosis antigens that are not present in any other mycobacteria. These findings may have a major impact on improved diagnostics for Johne's disease.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Johne's disease, caused by infection of ruminant animals with Mycobacterium avium subsp. paratuberculosis, has resulted in significant economic losses to the dairy and beef cattle industries (7, 29). A recent survey estimated that 21% of dairy herds in the United States are infected with M. avium subsp. paratuberculosis and that producers lose $227 annually for each infected animal, totaling more than $200 million annually (29). The control of Johne's disease has long been hampered by diagnostic tests that cannot consistently detect infected animals (17, 38). A major challenge in controlling Johne's disease is the ability to detect M. avium subsp. paratuberculosis-infected cattle prior to the appearance of disease signs, such as fecal shedding of M. avium subsp. paratuberculosis in the environment. In particular, subclinical infections are difficult to diagnose due to the lack of disease signs and intermittent shedding of the pathogen (34).

With this critical need for improved diagnostic tests to detect paratuberculosis infection, efforts need to be concentrated on the development of simple, rapid, noninvasive tests that can be performed by veterinarians or producers without expensive laboratory equipment. Bacteriologic culture is the most definitive method of diagnosis, since it can detect infection during both the subclinical and clinical stages of disease, but it is time-consuming, requiring as many as 12 weeks of incubation, and also labor-intensive (taking medium preparation into account). Contamination is an added problem when M. avium subsp. paratuberculosis is being cultured from fecal specimens. The intradermal skin test evaluates the delayed-type hypersensitivity reaction of an animal by injection of M. avium subsp. paratuberculosis extracts; however, problems involving antigenic cross-reactivity with other mycobacteria have limited its usefulness (12). Serologic tests for diagnosis of paratuberculosis such as agar gel immunodiffusion, enzyme-linked immunosorbent assay (ELISA), and complement-fixation are relatively easy to perform but suffer from a lack of specificity (8, 11). In tests that measure a cell-mediated host response, it has been demonstrated that young calves and uninfected cattle often respond to mycobacterial whole-cell antigen mixtures or secreted proteins in the gamma interferon test without showing any evidence of infection (22); that study also suggests that specificity could be improved by using defined, specific antigens. Currently, all antigen-based diagnostic tests for Johne's disease use a complex mixture of antigens, many of which are highly conserved among mycobacterial species. New approaches are needed to identify specific DNA sequences or antigens that will yield better diagnostic reagents for Johne's disease. However, no M. avium subsp. paratuberculosis-specific antigens have been described to date.

Although several antigens have been identified in mycobacteria, particularly Mycobacterium tuberculosis, fewer than 20 have been identified in M. avium subsp. paratuberculosis. Among these are the heat shock proteins GroES (9) and GroEL (14), 2 alkyl hydroperoxide reductases (25), a serine protease (6), superoxide dismutase (21), and 11 other proteins of unknown function that are named on the basis of their sizes in kilodaltons (3, 10, 13, 15, 16, 23, 24, 26-28, 33, 37). Some of these antigens appear to show promise, but none has been incorporated as a routine diagnostic tool according to the published literature and available commercial tests. This may be due, at least in part, to the presence of these antigens in other mycobacterial species. The close genetic relationship between M. avium subsp. paratuberculosis and M. avium subsp. avium has hindered progress in the identification of specific antigens for M. avium subsp. paratuberculosis. Greater than 95% nucleotide similarity exists between most strains of M. avium subsp. paratuberculosis and M. avium (4, 18, 32). Their genome sizes are also similar at 5 million bases. This has led to the proposal that the organism previously known as Mycobacterium paratuberculosis be considered a subspecies of M. avium subsp. avium (36). Work from our laboratories reveals substantial levels of genetic identity even above that previously described in the literature, further complicating efforts at developing a specific and sensitive diagnostic test (4).

The recent completion of the M. avium subsp. paratuberculosis genome project (L.-L. Li, J. P. Bannantine, Q. Zhang, D. Alt, A. Amonsin, and V. Kapur, unpublished data) will herald a dramatic acceleration in the understanding of the biology of this significant veterinary pathogen. Another critical step will be learning the functional roles of all the proteins encoded by the genome. Achievement of this objective depends on the rapid expression and purification of proteins on a large scale. A comparison between the recently completed genomes of M. avium subsp. paratuberculosis and M. avium strain 104 (sequenced at The Institute for Genomic Research) has already been performed (2). That study identified 21 predicted coding sequences that are specific to M. avium subsp. paratuberculosis. The specificity of these 21 sequences was maintained following analysis of 9 additional mycobacterial species by PCR amplification (2). In this study, we address the critical importance of identifying species-specific antigens for the serodiagnosis of Johne's disease through the cloning, heterologous expression, and analysis of those 21 unique predicted coding sequences found in the M. avium subsp. paratuberculosis genome.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Bacterial strains. M. avium subsp. paratuberculosis K-10, a bovine clinical isolate from a dairy herd in Wisconsin, was cultured in Middlebrook 7H9 broth (pH 6.0) supplemented with oleic acid-albumin-dextrose-catalase (Becton Dickinson Microbiology, Sparks, Md.), 0.05% Tween 80, and ferric mycobactin J (2 mg/liter; Allied Monitor Inc., Fayette, Mo.). This strain served as the source of the template for all PCR amplifications. Escherichia coli DH5 was routinely grown in Luria-Bertani broth (LB) and maintained on LB agar plates. All maltose binding protein (MBP) fusions were constructed in this strain. E. coli TOP10F' and E. coli BL21(DE3) (both from Invitrogen Life Technologies, Carlsbad, Calif.) cells were cultured in SOC medium prepared according to Sambrook et al. (31a). When appropriate, ampicillin (50 or 100 µg/ml) was added to the medium for selection. Frozen stocks were prepared by harvesting mid-log-phase cells in fresh LB supplemented with 20% glycerol and storing at -80°C.

Cloning of M. avium subsp. paratuberculosis-specific sequences. MBP fusions of 21 M. avium subsp. paratuberculosis predicted coding sequences were produced in E. coli by using the pMAL-c2 vector (New England Biolabs, Beverly, Mass.). These coding sequences and their nucleotide accession numbers have been described previously (2) and are designated genes 10, 11, 38, 56, 57, 135, 159, 217, 218, 219, 228, 240, 241, 250, 251, 252, 253, 254, 255, 256, and 257. Primers were designed from the reading frame of each coding sequence and contained an XbaI site in the 5' primer and a HindIII site in the 3' primer for cloning purposes. Amplifications were performed by using Pwo polymerase (Roche Diagnostics Corp., Indianapolis, Ind.) and M. avium subsp. paratuberculosis genomic DNA as the template under conditions described previously (2). The vector and amplification product were digested with XbaI and HindIII. Ligation of these restricted DNA fragments resulted in an in-frame fusion between the malE gene in the vector and the reading frame of interest. Following ligation, the products were transformed into E. coli DH5 and selected on LB agar plates containing 100 µg of ampicillin/ml. The pCRT7/CT-TOPO vector (Invitrogen Life Technologies) was used to produce polyhistidine (six-His)-tagged M. avium subsp. paratuberculosis proteins. No restriction sites were engineered in primers used in these amplifications, because each gel-purified PCR product was cloned into the vector by using topoisomerase. The construct was transformed into E. coli TOP10F' cells and then subcloned into the BL21(DE3)/pLysS cells (Invitrogen Life Technologies). Transformed cells were plated on LB agar containing 50 µg of ampicillin/ml. Inserts in all plasmid constructions were confirmed by DNA sequencing. Table 1 lists the primers used to clone each gene in the E. coli expression vectors pMAL-c2 and pCRT7/CT-TOPO.

View this table: [in this window] [in a new window]

TABLE 1. Primers used to amplify and clone M. avium subsp. paratuberculosis-specific sequences

Protein expression. Each MBP fusion protein (e.g., MBP-gene 218) was overexpressed in E. coli by induction with 0.3 mM isopropyl-ß-D-thiogalactopyranoside (IPTG; Sigma, St. Louis, Mo.) and purified by affinity chromatography using an amylose resin supplied by New England Biolabs. A detailed protocol has been published previously (1). Expression of mycobacterial fusion proteins was monitored by GelCode Blue (Pierce Biotechnology Inc., Rockford, Ill.)-stained sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels and by immunoblot analysis with a monoclonal antibody against MBP (-MBP) developed at the National Animal Disease Center (NADC). The same approach was used for production and purification of all MBP fusion proteins. E. coli DH5 harboring the parental plasmid pMAL-c2 was expressed, purified, and used as a control in all experiments. Purified protein from this control strain consists of an MBP fusion of the LacZ alpha peptide. Expression of six-His-tagged M. avium subsp. paratuberculosis proteins was similarly induced with 0.3 mM IPTG. Three hours following induction, the cells were lysed by sonication and the recombinant protein was purified on TALON resin (Clontech, Palo Alto, Calif.) columns under denaturing conditions. Mycobacterial genes were expressed as soluble proteins with a C-terminal six-His tag downstream of the gene of interest. Expression of mycobacterial protein was monitored by immunoblot analysis with a horseradish peroxidase-conjugated monoclonal antibody to the six-His tag (Clontech). Purified fractions were pooled and dialyzed by using Slide-A-Lyzer cassettes (Pierce Biotechnology Inc.) in 1 liter of phosphate-buffered saline (PBS, comprising 150 mM NaCl and 10 mM NaPO₄ [pH 7.4]) with three exchanges at 4°C.

SDS-PAGE and immunoblotting. E. coli protein lysates were prepared as previously described (30). PAGE was performed using 12% (wt/vol) polyacrylamide gels. Proteins were electrophoretically transferred onto pure nitrocellulose filters (Schleicher & Schuell, Keene, N.H.) with the Trans Blot Cell (Bio-Rad Laboratories, Hercules, Calif.) in sodium phosphate buffer (25 mM; pH 7.8) at 0.8 amps for 90 min. After transfer, filters were blocked with PBS plus 2% bovine serum albumin (BSA) and 0.1% Tween 20 (PBS-BSA). Antisera were diluted as listed in Table 2 in PBS-BSA and were incubated on the blot at room temperature for 2 h. After three washes in PBS plus 0.1% Tween 20, blots were incubated for 1.5 h in either protein A-peroxidase (Pierce Biotechnology Inc.) or peroxidase-conjugated antibodies that detect mouse and cow antibodies (Pierce Biotechnology Inc.). All secondary antibodies were diluted 1:20,000 in PBS-BSA. The blots were again washed three times as described above and were developed for chemiluminescence by using Supersignal detection reagents (Pierce Biotechnology Inc.).

View this table: [in this window] [in a new window]

TABLE 2. Antisera used in this study

Sera from M. avium subsp. paratuberculosis-exposed rabbits and mice and from cattle with Johne's disease. New Zealand White rabbits were immunized with heat-killed (n = 3) or live (n = 1) preparations of M. avium subsp. paratuberculosis in earlier studies (35). BALB/c mice (n = 2) were immunized with a sonicated lysate of M. avium subsp. paratuberculosis K-10. This lysate was prepared by harvesting M. avium subsp. paratuberculosis at an optical density at 540 nm of 0.4, resuspending in cold PBS (1/100 of culture volume), and sonicating three times for 10 min each time, with a 10-min incubation on ice in between sonications. Cell debris was centrifuged out at 10,000 x g.

The NADC is a national leader in large animal biocontainment. There are currently more than 20 head of cattle (holsteins and Brown Swiss) housed at the NADC for Johne's disease research activities. Control cattle are allowed to graze on pastures, whereas clinical cows are held in BL2 animal barns at NADC. Sera from 10 well-characterized cattle in the clinical stage of Johne's disease (shedding more than 100 bacilli per g of feces as determined by plate counts on Middlebrook 7H9 slopes) and 9 control cattle were used in immunoblot analysis for detection of antibodies that bind unique M. avium subsp. paratuberculosis proteins. Table 2 lists all sera used in these studies. All cattle sera were diluted 1:500 in immunoblot assays.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Cloning, expression, and purification of M. avium subsp. paratuberculosis sequences in E. coli. Twenty-one predicted coding sequences that are present uniquely in M. avium subsp. paratuberculosis have been identified previously (2). The deduced polypeptides produced from these coding sequences have no known peptide motifs or sequence similarity to other proteins in public databases such as GenBank. Each of these coding sequences was amplified from purified M. avium subsp. paratuberculosis genomic DNA and cloned into an E. coli expression vector as described in Materials and Methods. Because affinity purification tags coexpressed with the protein of interest can profoundly influence stability, solubility, and expression levels of recombinant protein, we evaluated two different affinity tags with each protein of interest. Predicted coding sequences were expressed in conjunction with either a six-His tag (5) or the 42-kDa MBP tag (31) for affinity purification. Efforts to clone and express each of the coding regions yielded various degrees of success with each tag. All of the MBP fusion proteins were successfully expressed and purified, although protein yields were very different (Fig. 1A). Coding sequences designated genes 253 (Fig. 1A, lane 3), 57 (lane 11), 252 (lane 16), 135 (lane 19), 217 (lane 20), 257 (lane 21), and 254 (lane 23) and the C-terminal half of gene 218 (218-C) (lane 25) were all expressed to high levels in E. coli. Other coding sequences including genes 219 (Fig. 1, lane 8), 256 (lane 18), and 250 (lane 22) were only marginally produced by E. coli. Still other proteins showed multiple bands (gene 159 [lane 5] and gene 251 [lane 4]), possibly due to proteolytic cleavage. Conversely, only 5 of the 21 six-His tag clones produced recombinant M. avium subsp. paratuberculosis protein, and those that did, produced a relatively small yield that could be detected only by immunoblotting (Fig. 2). Therefore, this study focused only on the MBP fusion proteins that were expressed and purified from E. coli. Table 3 lists the number of deduced amino acids, predicted antigenicity, calculated molecular size, and purification yield for each MBP fusion protein.

View larger version (81K): [in this window] [in a new window]

FIG. 1. SDS-PAGE and immunoblot analysis of affinity-purified M. avium subsp. paratuberculosis gene products. (A) Shown are two SDS-12% PAGE gels loaded with affinity-purified MBP fusion proteins that were stained with GelCode Blue. Size standards (in kilodaltons) are indicated on the left. (B through E) Corresponding immunoblots were probed with a monoclonal antibody to MBP (B) or with serum from rabbit 275 (C), mouse 47 (D), and clinical cow 67 (E). Note that MBP is not detected in panel C, D, or E. Lanes: 1, protein size standards; 2, gene 255; 3, gene 253; 4, gene 251; 5, gene 159; 6, gene 228; 7, gene 10; 8, gene 219; 9, gene 38; 10, gene 56; 11, gene 57; 12, MBP-MMP; 13, gene 218 (N-terminal half); 14, protein size standards; 15, gene 241; 16, gene 252; 17, gene 240; 18, gene 256; 19, gene 135; 20, gene 217; 21, gene 257; 22, gene 250; 23, gene 254; 24, gene 11; 25, gene 218 (C-terminal half); 26, MBP. Arrows point to the five subspecies-specific antigens identified in this study.

View larger version (98K): [in this window] [in a new window]

FIG. 2. Expression of M. avium subsp. paratuberculosis six-His tag clones in E. coli. An immunoblot containing IPTG-induced E. coli BL21(DE3) lysates was probed with a monoclonal antibody that detects the polyhistidine tag. Size standards (in kilodaltons) are indicated on the left. Lanes: 1, protein size standards; 2, gene 254; 3, gene 159; 4, gene 56; 5, gene 38; 6, gene 228; 7, E. coli BL21(DE3) cells.

View this table: [in this window] [in a new window]

TABLE 3. Characteristics of M. avium subsp. paratuberculosis MBP fusion proteins

Serological analysis of recombinant M. avium subsp. paratuberculosis proteins with rabbit and mouse sera. Each protein was next examined by immunoblot analysis with rabbit and mouse sera containing -M. avium subsp. paratuberculosis antibodies. Rabbits and mice that were immunized with various preparations of M. avium subsp. paratuberculosis are listed in Table 2. All fusion proteins were detected by a monoclonal antibody to the MBP tag (Fig. 1B); however, only five of the purified proteins were detected by -M. avium subsp. paratuberculosis antibodies present in both rabbit and mouse sera (Fig. 1C and D, respectively). These antigenic proteins are MBP-gene 56 (Fig. 1C and D, lanes 10), MBP-gene 218 (lanes 13 and 25), MBP-gene 241 (lanes 15), MBP-gene 135 (lanes 19), and MBP-gene 254 (lanes 23). Serological reactivity associated with the two fusion proteins encoded by genes 56 (lanes 10) and 135 (lanes 19) was readily visible in mouse (Fig. 1D) but not rabbit (Fig. 1C) serum. Additional immunoblotting experiments showed that the same five proteins were also detected by sera from mouse 48 and rabbits 273 and 274 (data not shown). One MBP fusion protein detected by the mouse serum only (Fig. 1D, lane 8) was not of the expected size and therefore was not considered further. In addition, a known M. avium subsp. paratuberculosis protein, termed the major membrane protein (MMP) (3), included as a control, was detected by both the rabbit and mouse sera (Fig. 1C and D, lanes 12), whereas the MBP control protein was detected by neither (Fig. 1C and D, lanes 26). These data suggest that at least five subspecies-specific proteins are produced by M. avium subsp. paratuberculosis and are immunogenic.

Reactivity to sera from control and Johne's disease cattle. To determine whether M. avium subsp. paratuberculosis fusion proteins will specifically react with antibodies from Johne's disease cattle, sera from 10 cattle in the clinical stage of Johne's disease were used in immunoblot experiments with the same set of purified proteins described above. Results of a typical experiment using serum from clinical cow 67 are shown in Fig. 1E. As was seen in the immunoblots with rabbit and mouse sera, both the N- and C-terminal halves of protein 218 were detected by serum from this clinical cow. In addition, products from genes 241 (lane 15), 135 (lane 19), and 254 (lane 23) were detected. The antigen produced from gene 56 (lane 10) may also be detected; however, this is not conclusive due to background present in that region of the immunoblot. We base this conclusion on the fact that the nonspecific binding occurs at a size range that is inconsistent with the predicted and observed size values of the recombinant purified proteins (as shown in Fig. 1A). However, this background (primarily a 50-kDa band) was not observed with the mouse or rabbit serum.

Serum from clinical cow 67 did not detect the MMP control protein (Fig. 1E, lane 12), although this protein was detected in sera from other clinical cattle (data not shown). Sera from nine additional cattle showing overt clinical disease were also evaluated against the five antigenic proteins listed in Table 4; however, four sera had antibodies to the MBP protein, making interpretation difficult (Table 4). Sera from cows 47, 167, and 598 detected all five immunogenic proteins, whereas sera from cows 14, 67, and Kay did not have antibodies to all five proteins. Only the MBP-gene 241 antigen was detected by all MBP-negative clinical sera tested. Control sera from five of nine healthy cows had antibodies to MBP, and only serum from animal 181 failed to react with any of the five proteins (Table 4).

View this table: [in this window] [in a new window]

TABLE 4. M. avium subsp. paratuberculosis reactivity with NADC cattle seraa

Top Abstract Introduction Materials and Methods Results Discussion References

 
Among the greatest needs for effectively combating Johne's disease are new diagnostic tools that more accurately identify animals infected with M. avium subsp. paratuberculosis. A highly specific test that could distinguish between infected and noninfected animals within herds might have a greater immediate impact on the U.S. dairy industry than any other current management approach, including vaccination. This is because accurate identification of infected animals would allow removal of only those animals from a herd. Therefore, developing an improved immunological assay for the detection of paratuberculosis-specific proteins is a critical research focus.

Unfortunately, the diagnosis of Johne's disease has long been hindered by the lack of sensitive and specific assays that detect M. avium subsp. paratuberculosis as well as a lack of antigens that distinguish it from other closely related mycobacteria, including M. avium subsp. avium. All antigen-based diagnostic tests for Johne's disease currently use a complex mixture of undefined antigens, such as purified protein derivative (PPD), that can exhibit cross-reactivity with other mycobacteria (17). In order to develop more-reliable antigen-based tests such as ELISAs, species-specific M. avium subsp. paratuberculosis antigens must first be identified. Investigators have long pursued the search for M. avium subsp. paratuberculosis-specific genes and antigens, with no progress until recently (2, 19). With the genome sequence for M. avium subsp. paratuberculosis now completed (Li et al., unpublished), a collection of 21 M. avium subsp. paratuberculosis-specific DNA sequences have been identified (2) and another 14 are still under evaluation (M. L. Paustian, V. Kapur, and J. P. Bannantine, unpublished data). The present study represents an initial effort to heterologously express these sequences and evaluate their antigenic character. These studies have shown that of the 21 predicted coding sequences analyzed, 5 (genes 56, 135, 218, 241, and 254) encode proteins that appear to be immunogenic. It is noteworthy that, except for gene 241, no single antigen was detected by all MBP-negative cattle sera tested. However, sera from subclinically infected cows have yet to be tested, and it is possible that all five proteins may not be detected at that stage of infection. While this finding highlights the gene 241 sequence as a potential diagnostic antigen, it also underscores the need for a "cocktail" consisting of more than a single specific antigen to expand the possibility that at least one of the antigens might be detected at all stages of the disease. This strategy of combining several M. avium subsp. paratuberculosis-specific proteins should theoretically result in greater sensitivity as well.

Despite the fact that each of the proteins is encoded by genes present only in M. avium subsp. paratuberculosis, there remains the possibility that epitopes may be conserved with proteins from other mycobacteria and may therefore cross-react with sera from animals exposed to other mycobacteria. However, none of these five immunogenic proteins have significant similarities to any protein in the public databases, and their functions remain unknown. Furthermore, there are no known protein motifs present. Hence, the likelihood of true cross-reactivity is diminished. Nonetheless, raising polyclonal antibodies against M. avium and evaluating their reactivity to these purified M. avium subsp. paratuberculosis proteins is one of the strategies that we are using to identify possible immunologic cross-reactivity of these proteins due to shared epitopes. The novelty and lack of similarity in these M. avium subsp. paratuberculosis sequences suggests that they would have remained unknown if not discovered through a whole-genome sequencing effort. Research directed at elucidating the functions of these proteins will provide a better understanding of why M. avium subsp. paratuberculosis is so phenotypically different from other closely related mycobacteria.

By using denaturing conditions for protein purification, all of the MBP fusions were purified. In contrast to the MBP-M. avium subsp. paratuberculosis fusion proteins, only five mycobacterial proteins were successfully expressed by using the polyhistidine tag. Each affinity tag used in this study has distinct advantages and disadvantages. Generally, expression of recombinant proteins as a fusion with MBP can overcome problems such as toxicity in E. coli, low expression levels, inclusion body formation, and insolubility (31). Our data appear to substantiate this observation in that a higher percentage of recombinant protein was produced with the MBP system than with the polyhistidine system. The disadvantage of MBP is the size and immunogenicity of the affinity tag, which complicates any downstream immunoassays. The MBP tag must be included as a control in experiments where the protein of interest could not be separated from the MBP tag with a protease such as factor Xa. Conversely, the polyhistidine tag is small and does not react with most sera. However, in our hands, several mycobacterial proteins were not expressed with this system and purification to homogeneity was not achieved.

Unlike the rabbit and mouse antisera, several cattle sera detected MBP. This result severely limited the number of cattle that could be used in these analyses. The outbred nature of cattle is conducive to exposure to environmental antigens such as E. coli MBP or M. avium proteins. Therefore, in order for these novel antigens to be incorporated into a routine diagnostic test, the proteins must be expressed and purified without the MBP affinity tag. Nonetheless, these five novel M. avium subsp. paratuberculosis antigens are perhaps the most promising diagnostic antigens identified to date.

These data show that at least some of the coding predictions were correct for the novel M. avium subsp. paratuberculosis genes. However, many of the 21 gene products were not detected by any of the sera. Three possibilities could account for this result. The coding sequence prediction may be incorrect, or in the wrong reading frame. Alternatively, the mycobacterial protein may not be folded or modified correctly in E. coli. Another possibility is that the gene product may actually be produced by M. avium subsp. paratuberculosis but may simply not be immunogenic. A limitation of the experimental design used in this study is that successful identification of an antigen depends on two variables. First, the protein expressed from each predicted coding sequence must actually be produced by M. avium subsp. paratuberculosis, and second, that protein must be immunogenic. To eliminate the dependence on these two variables, a proteomic approach is needed to bypass the requirement of antigenicity by confirming coding sequence predictions solely on the basis of protein profiles in two-dimensional SDS-PAGE gels and subsequent protein sequence determination by matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) spectrophotometry.

In conclusion, this study demonstrates that serological analysis of recombinant proteins produced from M. avium subsp. paratuberculosis-specific sequences can lead to the identification of novel antigens that may be useful for diagnosis. These antigens may be able to distinguish M. avium subsp. paratuberculosis from other closely related mycobacteria. In order to ensure that reactivity was reliable, we have tested these antigens with sera from three different species of hosts including mice, rabbits, and naturally infected cattle. The evaluation of these antigens as diagnostic reagents will be expanded with field studies on well-characterized dairy herds.

 
This work was supported by the USDA's Agricultural Research Service and USDA-NRI grants to J.P.B. and V.K.

The expert technical assistance of Trudy L. Bosworth is gratefully acknowledged.

 
* Corresponding author. Mailing address: National Animal Disease Center, ARS—USDA, 2300 North Dayton Ave., Ames, IA 50010. Phone: (515) 663-7340. Fax: (515) 663-7458. E-mail: jbannant{at}nadc.ars.usda.gov.

Top Abstract Introduction Materials and Methods Results Discussion References

 

1
1. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1987. Current protocols in molecular biology. Greene Publishing Associates and Wiley-Interscience, New York, N.Y.
2
2. Bannantine, J. P., E. Baechler, Q. Zhang, L. Li, and V. Kapur. 2002. Genome scale comparison of Mycobacterium avium subsp. paratuberculosis with Mycobacterium avium subsp. avium reveals potential diagnostic sequences. J. Clin. Microbiol. 40:1303-1310.[Abstract/Free Full Text]
3
3. Bannantine, J. P., and J. R. Stabel. 2001. Identification of two Mycobacterium avium subspecies paratuberculosis gene products differentially recognised by sera from rabbits immunised with live mycobacteria but not heat-killed mycobacteria. J. Med. Microbiol. 50:795-804.[Abstract/Free Full Text]
4
4. Bannantine, J. P., Q. Zhang, L. Li, and V. Kapur. 2003. Genomic homogeneity between Mycobacterium avium subsp. avium and Mycobacterium avium subsp. paratuberculosis belies their divergent growth rates. BMC Microbiol. 3:10.[CrossRef][Medline]
5
5. Bornhorst, J. A., and J. J. Falke. 2000. Purification of proteins using polyhistidine affinity tags. Methods Enzymol. 326:245-254.[CrossRef][Medline]
6
6. Cameron, R. M., K. Stevenson, N. F. Inglis, J. Klausen, and J. M. Sharp. 1994. Identification and characterization of a putative serine protease expressed in vivo by Mycobacterium avium subsp. paratuberculosis. Microbiology 140:1977-1982.[Abstract/Free Full Text]
7
7. Chi, J., J. VanLeeuwen, A. Weersink, and G. Keefe. 2002. Direct production losses and treatment costs from bovine viral diarrhea virus, bovine leukosis virus, Mycobacterium avium subspecies paratuberculosis, and Neospora caninum. Prev. Vet. Med. 55:137.[CrossRef][Medline]
8
8. Clarke, C. J., I. A. Patterson, K. E. Armstrong, and J. C. Low. 1996. Comparison of the absorbed ELISA and agar gel immunodiffusion test with clinicopathological findings in ovine clinical paratuberculosis. Vet. Rec. 139:618-621.[Abstract/Free Full Text]
9
9. Cobb, A. J., and R. Frothingham. 1999. The GroES antigens of Mycobacterium avium and Mycobacterium paratuberculosis. Vet. Microbiol. 67:31-35.[CrossRef][Medline]
10
10. Coetsier, C., X. Havaux, F. Mattelard, S. Sadatte, F. Cormont, K. Buergelt, B. Limbourg, D. Latinne, H. Bazin, J. F. Denef, and C. Cocito. 1998. Detection of Mycobacterium avium subsp. paratuberculosis in infected tissues by new species-specific immunohistological procedures. Clin. Diagn. Lab. Immunol. 5:446-451.[Abstract/Free Full Text]
11
11. Colgrove, G. S., C. O. Thoen, B. O. Blackburn, and C. D. Murphy. 1989. Paratuberculosis in cattle: a comparison of three serologic tests with results of fecal culture. Vet. Microbiol. 19:183-187.[CrossRef][Medline]
12
12. Collins, M. T. 1996. Diagnosis of paratuberculosis. Vet. Clin. N. Am. Food Anim. Pract. 12:357-371.[Medline]
13
13. De Kesel, M., P. Gilot, M. Coene, and C. Cocito. 1992. Composition and immunological properties of the protein fraction of A36, a major antigen complex of Mycobacterium paratuberculosis. Scand. J. Immunol. 36:201-212.[CrossRef][Medline]
14
14. el-Zaatari, F. A., S. A. Naser, L. Engstrand, P. E. Burch, C. Y. Hachem, D. L. Whipple, and D. Y. Graham. 1995. Nucleotide sequence analysis and seroreactivities of the 65K heat shock protein from Mycobacterium paratuberculosis. Clin. Diagn. Lab. Immunol. 2:657-664.[Abstract]
15
15. el-Zaatari, F. A., S. A. Naser, L. Engstrand, C. Y. Hachem, and D. Y. Graham. 1994. Identification and characterization of Mycobacterium paratuberculosis recombinant proteins expressed in E. coli. Curr. Microbiol. 29:177-184.[CrossRef][Medline]
16
16. Gilot, P., M. De Kesel, L. Machtelinckx, M. Coene, and C. Cocito. 1993. Isolation and sequencing of the gene coding for an antigenic 34-kilodalton protein of Mycobacterium paratuberculosis. J. Bacteriol. 175:4930-4935.[Abstract/Free Full Text]
17
17. Harris, N. B., and R. G. Barletta. 2001. Mycobacterium avium subsp. paratuberculosis in veterinary medicine. Clin. Microbiol. Rev. 14:489-512.[Abstract/Free Full Text]
18
18. Hurley, S. S., G. A. Splitter, and R. A. Welch. 1989. Development of a diagnostic test for Johne's disease using a DNA hybridization probe. J. Clin. Microbiol. 27:1582-1587.[Abstract/Free Full Text]
19
19. Klitgaard Nielsen, K., and P. Ahrens. 2002. Putative in vitro expressed gene fragments unique to Mycobacterium avium subspecies paratuberculosis. FEMS Microbiol. Lett. 214:199.[CrossRef][Medline]
20
20. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:1005-1032.
21
21. Liu, X., Z. Feng, N. B. Harris, J. D. Cirillo, H. Bercovier, and R. G. Barletta. 2001. Identification of a secreted superoxide dismutase in Mycobacterium avium ssp. paratuberculosis. FEMS Microbiol. Lett. 202:233-238.[CrossRef][Medline]
22
22. McDonald, W. L., S. E. Ridge, A. F. Hope, and R. J. Condron. 1999. Evaluation of diagnostic tests for Johne's disease in young cattle. Aust. Vet. J. 77:113-119.[Medline]
23
23. Mullerad, J., A. H. Hovav, R. Nahary, Y. Fishman, and H. Bercovier. 2003. Immunogenicity of a 16.7 kDa Mycobacterium paratuberculosis antigen. Microb. Pathog. 34:81-90.[CrossRef][Medline]
24
24. Mutharia, L. M., W. Moreno, and M. Raymond. 1997. Analysis of culture filtrate and cell wall-associated antigens of Mycobacterium paratuberculosis with monoclonal antibodies. Infect. Immun. 65:387-394.[Abstract]
25
25. Olsen, I., L. J. Reitan, G. Holstad, and H. G. Wiker. 2000. Alkyl hydroperoxide reductases C and D are major antigens constitutively expressed by Mycobacterium avium subsp. paratuberculosis. Infect. Immun. 68:801-808.[Abstract/Free Full Text]
26
26. Olsen, I., and A. K. Storset. 2001. Innate IFN- production in cattle in response to MPP14, a secreted protein from Mycobacterium avium subsp. Paratuberculosis. Scand. J. Immunol. 54:306-313.
27
27. Olsen, I., M. Tryland, H. G. Wiker, and L. J. Reitan. 2001. AhpC, AhpD, and a secreted 14-kilodalton antigen from Mycobacterium avium subsp. paratuberculosis distinguish between paratuberculosis and bovine tuberculosis in an enzyme-linked immunosorbent assay. Clin. Diagn. Lab. Immunol. 8:797-801.[Abstract/Free Full Text]
28
28. Olsen, I., H. G. Wiker, E. Johnson, H. Langeggen, and L. J. Reitan. 2001. Elevated antibody responses in patients with Crohn's disease against a 14-kDa secreted protein purified from Mycobacterium avium subsp. paratuberculosis. Scand. J. Immunol. 53:198-203.
29
29. Ott, S. L., S. J. Wells, and B. A. Wagner. 1999. Herd-level economic losses associated with Johne's disease on US dairy operations. Prev. Vet. Med. 40:179-192.[CrossRef][Medline]
30
30. Rockey, D. D., and J. L. Rosquist. 1994. Protein antigens of Chlamydia psittaci present in infected cells but not detected in the infectious elementary body. Infect. Immun. 62:106-112.[Abstract/Free Full Text]
31
31. Sachdev, D., and J. M. Chirgwin. 2000. Fusions to maltose-binding protein: control of folding and solubility in protein purification. Methods Enzymol. 326:312-321.[Medline]
31
32. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
32
33. Saxegaard, F., and I. Baess. 1988. Relationship between Mycobacterium avium, Mycobacterium paratuberculosis and "wood pigeon mycobacteria." Determinations by DNA-DNA hybridization. APMIS 96:37-42.[Medline]
33
34. Silbaq, F. S., S. N. Cho, S. T. Cole, and P. J. Brennan. 1998. Characterization of a 34-kilodalton protein of Mycobacterium leprae that is isologous to the immunodominant 34-kilodalton antigen of Mycobacterium paratuberculosis. Infect. Immun. 66:5576-5579.[Abstract/Free Full Text]
34
35. Stabel, J. R. 1998. Johne's disease: a hidden threat. J. Dairy Sci. 81:283-288.[Abstract]
35
36. Stabel, J. R., M. R. Ackermann, and J. P. Goff. 1996. Comparison of polyclonal antibodies to three different preparations of Mycobacterium paratuberculosis in immunohistochemical diagnosis of Johne's disease in cattle. J. Vet. Diagn. Investig. 8:469-473.[Abstract/Free Full Text]
36
37. Thorel, M. F., M. Krichevsky, and V. V. Levy-Frebault. 1990. Numerical taxonomy of mycobactin-dependent mycobacteria, emended description of Mycobacterium avium, and description of Mycobacterium avium subsp. avium subsp. nov., Mycobacterium avium subsp. paratuberculosis subsp. nov., and Mycobacterium avium subsp. silvaticum subsp. nov. Int. J. Syst. Bacteriol. 40:254-260.[Abstract/Free Full Text]
37
38. White, W. B., D. L. Whipple, J. R. Stabel, and C. A. Bolin. 1994. Comparison of cellular and extracellular proteins expressed by various isolates of Mycobacterium paratuberculosis and other mycobacterial species. Am. J. Vet. Res. 55:1399-1405.[Medline]
38
39. Whitlock, R. H., and C. Buergelt. 1996. Preclinical and clinical manifestations of paratuberculosis (including pathology). Vet. Clin. N. Am. Food Anim. Pract. 12:345-356.[Medline]

---

Journal of Clinical Microbiology, January 2004, p. 106-114, Vol. 42, No. 1
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.1.106-114.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Janagama, H. K., Senthilkumar, T. M. A., Bannantine, J. P., Rodriguez, G. M., Smith, I., Paustian, M. L., McGarvey, J. A., Sreevatsan, S. (2009). Identification and functional characterization of the iron-dependent regulator (IdeR) of Mycobacterium avium subsp. paratuberculosis. Microbiology 155: 3683-3690 [Abstract] [Full Text]  
• Mackenzie, N., Alexander, D. C., Turenne, C. Y., Behr, M. A., De Buck, J. M. (2009). Genomic Comparison of PE and PPE Genes in the Mycobacterium avium Complex. J. Clin. Microbiol. 47: 1002-1011 [Abstract] [Full Text]  
• Hughes, V., Bannantine, J. P., Denham, S., Smith, S., Garcia-Sanchez, A., Sales, J., Paustian, M. L., Mclean, K., Stevenson, K. (2008). Immunogenicity of Proteome-Determined Mycobacterium avium subsp. paratuberculosis-Specific Proteins in Sheep with Paratuberculosis. CVI 15: 1824-1833 [Abstract] [Full Text]  
• Bannantine, J. P., Paustian, M. L., Waters, W. R., Stabel, J. R., Palmer, M. V., Li, L., Kapur, V. (2008). Profiling Bovine Antibody Responses to Mycobacterium avium subsp. paratuberculosis Infection by Using Protein Arrays. Infect. Immun. 76: 739-749 [Abstract] [Full Text]  
• Ventura, M., Canchaya, C., Tauch, A., Chandra, G., Fitzgerald, G. F., Chater, K. F., van Sinderen, D. (2007). Genomics of Actinobacteria: Tracing the Evolutionary History of an Ancient Phylum. Microbiol. Mol. Biol. Rev. 71: 495-548 [Abstract] [Full Text]  
• Li, L., Munir, S., Bannantine, J. P., Sreevatsan, S., Kanjilal, S., Kapur, V. (2007). Rapid Expression of Mycobacterium avium subsp. paratuberculosis Recombinant Proteins for Antigen Discovery. CVI 14: 102-105 [Abstract] [Full Text]  
• Patel, D., Danelishvili, L., Yamazaki, Y., Alonso, M., Paustian, M. L., Bannantine, J. P., Meunier-Goddik, L., Bermudez, L. E. (2006). The Ability of Mycobacterium avium subsp. paratuberculosis To Enter Bovine Epithelial Cells Is Influenced by Preexposure to a Hyperosmolar Environment and Intracellular Passage in Bovine Mammary Epithelial Cells.. Infect. Immun. 74: 2849-2855 [Abstract] [Full Text]  
• Griffin, J. F. T., Spittle, E., Rodgers, C. R., Liggett, S., Cooper, M., Bakker, D., Bannantine, J. P. (2005). Immunoglobulin G1 Enzyme-Linked Immunosorbent Assay for Diagnosis of Johne's Disease in Red Deer (Cervus elaphus). CVI 12: 1401-1409 [Abstract] [Full Text]  
• Huntley, J. F., Stabel, J. R., Paustian, M. L., Reinhardt, T. A., Bannantine, J. P. (2005). Expression Library Immunization Confers Protection against Mycobacterium avium subsp. paratuberculosis Infection. Infect. Immun. 73: 6877-6884 [Abstract] [Full Text]  
• Stabel, J. R., Bannantine, J. P. (2005). Development of a Nested PCR Method Targeting a Unique Multicopy Element, ISMap02, for Detection of Mycobacterium avium subsp. paratuberculosis in Fecal Samples. J. Clin. Microbiol. 43: 4744-4750 [Abstract] [Full Text]  
• Li, L., Bannantine, J. P., Zhang, Q., Amonsin, A., May, B. J., Alt, D., Banerji, N., Kanjilal, S., Kapur, V. (2005). The complete genome sequence of Mycobacterium avium subspecies paratuberculosis. Proc. Natl. Acad. Sci. USA 102: 12344-12349 [Abstract] [Full Text]  
• Semret, M., Alexander, D. C., Turenne, C. Y., de Haas, P., Overduin, P., van Soolingen, D., Cousins, D., Behr, M. A. (2005). Genomic Polymorphisms for Mycobacterium avium subsp. paratuberculosis Diagnostics. J. Clin. Microbiol. 43: 3704-3712 [Abstract] [Full Text]  
• Paustian, M. L., Kapur, V., Bannantine, J. P. (2005). Comparative Genomic Hybridizations Reveal Genetic Regions within the Mycobacterium avium Complex That Are Divergent from Mycobacterium avium subsp. paratuberculosis Isolates. J. Bacteriol. 187: 2406-2415 [Abstract] [Full Text]  
• Paustian, M. L., Amonsin, A., Kapur, V., Bannantine, J. P. (2004). Characterization of Novel Coding Sequences Specific to Mycobacterium avium subsp. paratuberculosis: Implications for Diagnosis of Johne's Disease. J. Clin. Microbiol. 42: 2675-2681 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bannantine, J. P. Articles by Kapur, V. Search for Related Content PubMed PubMed Citation Articles by Bannantine, J. P. Articles by Kapur, V.